Eni and Saudi Aramco were part of Pasqal’s $109m series B round while Boston Scientific and GSK helped SetPoint Medical pull in $80m.

Funds Japanese chemical and life sciences group Denka has teamed up with US-based venture capital firm Pegasus Tech Ventures to form a $100m corporate venturing fund. Denka will be the sole limited partner for the fund, which will invest between $500,000 and $10m per deal in areas like renewable energy, batteries, semiconductors and healthcare. US-based…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.